DEVELOPMENT OF DRUGS ACTING AT ADENOSINE RECEPTORS
作用于腺苷受体的药物的开发
基本信息
- 批准号:3776298
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The extracellular adenosine receptor has a modulatory role in the
nervous, circulatory, endocrine, and immunological systems. The prospect
of harnessing these effects specifically for therapeutic purposes is
attractive.
We have developed research tools for the characterization of adenosine
receptors in vitro and in vivo. We have synthesized new drug analogues
and elucidated structure activity relationships at receptor subtypes.
Derivatives of adenosine with chemical modifications at the N6 and C-2
positions of the purine ring act as selective adenosine agonists. Al-
agonists are being explored as cerebroprotective agents. To enhance
brain uptake, prodrug schemes are being examined. APEC, and A2 selective
adenosine amine congener served as the basis for a photoaffinity labeling
reagent that allowed the first determination of the molecular weight of
the receptor. Functionalized congeners of xanthines act as potent
adenosine antagonists and are being developed as radioactive tracers for
adenosine receptors and as affinity labels. Peripherally selective
adenosine agonists have been developed.
Since the two major subtypes of adenosine receptors have been cloned it
has been possible to conduct molecular modeling of the receptor protein,
based on sequence analyses and computerized energy minimizations. A
hypothesis concerning the mode of binding to ligands to adenosine
receptors has been derived. This hypothesis is consistent with
pharmacological observations and site directed mutagenesis experiments,
in which key histidyl residues have been replaced by other amino acids.
胞外腺苷受体在细胞凋亡中起调节作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
K JACOBSON其他文献
K JACOBSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('K JACOBSON', 18)}}的其他基金
PROSTHETIC GROUPS FOR RADIOLABELING OF FUNCTIONALIZED DRUGS AND PEPTIDES
用于功能化药物和肽的放射性标记的辅基
- 批准号:
3875624 - 财政年份:
- 资助金额:
-- - 项目类别:














{{item.name}}会员




